Abstract:Abstract Cyclin D1 is a key regulator of the G1 to S transition of the cell cycle, physiologically absent in normal lymphocytes, but overexpressed in some lymphoproliferative disorders such as mantle cell lymphoma or multiple myeloma. While cyclin D1 has also been shown to control other aspects of the cellular fate, such as cellular senescence, apoptosis or tumorigenesis, its precise role in the pathogenesis of B-cell lymphomas and leukemias is still unclear. In this context, using various cell lines derived from the pre-B murine cell line BaF3 and conditionally expressing cyclin D1, we have previously reported that when expressed at a level comparable to the one detected in tumoral cells, cyclin D1 impairs cell proliferation mainly by inducing apoptosis. We now report that the BaF3-derived cell line BD1-A21, which constitutively expresses a low but notable level of cyclin D1, presents a recurrent resistance towards various apoptotic stimuli involving different signaling pathways, such as cytokine withdrawal, etoposide treatment and staurosporine-mediated kinases inhibition, when compared to the parental BaF3 cells. This lack of sensitivity towards apoptosis was correlated in cyclin D1-expressing cells with an increase in the basal levels of several antiapoptotic factors such as IAPs (c-IAP1, c-IAP2, XIAP and survivin) or the death receptors pathway inhibitor cFLIP, and the relative maintenance of these factors in IL-3-starved cells. 2D-PAGE analysis also pointed out in cyclin D1 expressing cells the accumulation of a series of molecular chaperones, which the most overexpressed is hsp70, concording with previous works describing the cyclin D1-dependent synthesis of hsp70 in lymphoid cells. Consistently with a protective role of hsp70 in cyclin D1-expressing cells, its pharmacological inhibition by the mean of the flavonoid quercetin allowed to re-sensitize BD1-A21 cells to the apoptotic stimulus evoked by IL-3 starvation. Hsp70 protective efect appeared to act upstream of mitochondrion, as determined by mesurement of mitochondrial membrane potential and western-blot or FACS analysis of the main Bcl-2 family members. The relationship between cyclin D1 constitutive expression, antiapoptotic factors and chaperones accumulation, and resistance to apoptosis is currently under investigation.

P21/cyclin E Pathway Modulates Anticlastogenic Function of Bmi-1 in Cancer Cells

Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiPl

Cyclin B1 Stability is Increased by Interaction with BRCA1, and Its Overexpression Suppresses the Progression of BRCA1-associated Mammary Tumors

Cyclin A is essential for the p53-modulated inhibition from benzo(a)pyrene toxicity in A549 cells.

Overexpression of Cyclin B1 Antagonizes Chemotherapeutic-Induced Apoptosis Through Pten/Akt Pathway in Human Esophageal Squamous Cell Carcinoma Cells

p21: A Two-Faced Genome Guardian

P21 Disrupts the Interaction Between Cdk2 and the E2F-p130 Complex.

p21 in cancer: intricate networks and multiple activities

A Novel Cycline/cyclina-Cdk Inhibitor Targets P27(kip1) Degradation, Cell Cycle Progression and Cell Survival: Implications in Cancer Therapy.

Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1

HBP1-mediated Regulation of P21 Protein Through the Mdm2/p53 and TCF4/EZH2 Pathways and Its Impact on Cell Senescence and Tumorigenesis

Bmi1 Regulates Mitochondrial Function and the DNA Damage Response Pathway

Cyclin D1 Mediates Resistance towards p53-Independent and -Dependent Apoptosis through Anti-Apoptotic Factors and Molecular Chaperones.

The Multifaceted p21 (Cip1/Waf1/CDKN1A) in Cell Differentiation, Migration and Cancer Therapy

Immune recognition of cyclin B1 as a tumor antigen is a result of its overexpression in human tumors that is caused by non-functional p53.

Cyclin A but not cyclin D1 is essential for c-myc-modulated cell-cycle progression.

Bmi-1 Expression Modulates Non-Small Cell Lung Cancer Progression.

Inhibition of Cyclin-Dependent Kinases by P21.

Transcriptional repression of p21 by EIF1AX promotes the proliferation of breast cancer cells

Reciprocal antagonism of PIN1-APC/C CDH1 governs mitotic protein stability and cell cycle entry

The cGAS/STING/TBK1/IRF3 innate immunity pathway maintains chromosomal stability through regulation of p21 levels